Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-26 @ 1:01 AM
NCT ID: NCT02299934
Description: This study was terminated early due to lack of enrollment. No adverse events data was reported prior to early termination
Frequency Threshold: 0
Time Frame: Duration of study activity (approximately 2 years)
Study: NCT02299934
Study Brief: 3T MR Angiography of the Hepatic Vasculature
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Subjects Who Fulfill the Criteria for Living Liver Donation Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI). Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent. Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature. 0 None 0 13 0 13 View
Serious Events(If Any):
Other Events(If Any):